Pharmaceuticals News and Research

RSS

Re-engineered Multi-IR box accessory for the Integrity 10 Reaction Station launched by Electrothermal

Cole-Parmer Ltd, a leading UK manufacturer of laboratory equipment, announced today that Electrothermal has launched the re-engineered Multi-IR box accessory for the Integrity 10 Reaction Station. The Multi-IR box accessory, originally developed in conjunction with Pfizer and the Illinois Institute of Technology, enables scientists across a broad range of global industries and laboratories to measure turbidity in-situ during experiments.

From Cole Parmer Limited 5 Jul 2017

Researchers discover differences between mice and humans in function of insulin-producing beta cells

Research from King's College in London, UK, and Lund University in Sweden could explain why diabetes drugs which have worked in animal experiments are not equally successful in humans.

4 Jul 2017

'Brain training' game could help improve memory in patients with patients with amnestic MCI

A 'brain training' game developed by researchers at the University of Cambridge could help improve the memory of patients in the very earliest stages of dementia, suggests a study published today in The International Journal of Neuropsychopharmacology.

3 Jul 2017

NEI-funded research aims to prevent or reverse progression of cataracts

Research funded by the National Eye Institute aims to reverse progression of cataracts- the most common cause of blindness worldwide- or to prevent them from forming altogether.

30 Jun 2017

Wayne State researchers receive NIH grant to mimic benefits of exercise in sedentary patients

A team of researchers led by Robert Wessells, Ph.D., assistant professor of physiology in the School of Medicine at Wayne State University, has received a two-year, $423,500 grant from the National Institute on Aging of the National Institutes of Health for the project, "Octopamine mediates benefits of endurance exercise in Drosophila."

30 Jun 2017

Ondek raises capital to develop new treatment for childhood allergy

Ondek, the Australian biotechnology company founded by Nobel Laureate Professor Barry Marshall, today announced it raised A$3.59 million in equity funding from professional and high-net-worth investors to support his work to develop a new treatment for childhood allergy.

30 Jun 2017

Glooko raises $35 million to accelerate growth in data analytics to support diabetes community

Glooko, the leader in diabetes data management, today announced $35 million in new funding to accelerate growth, expand international presence, and deepen expertise in data analytics.

30 Jun 2017

Mitochondria-targeted antioxidant shows promise for diabetic wound treatment

Members of the Faculty of Biology and A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University, have tested on a mouse model a mitochondria-targeted antioxidant, helping to treat diabetic wounds.

29 Jun 2017

Research yields first successful isolation, maintenance of haploid embryonic stem cells in humans

Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their ability to turn into any cell in the human body, are essential to the future prevention and treatment of disease.

29 Jun 2017

DNA methylation can provide effective markers for major cancers, study reveals

In a new study, published online in the July 26 issue of PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China, report that DNA methylation can provide effective markers for at least four major cancers, not only correctly differentiating malignant tissues from normal, but also providing information on prognosis and survival.

28 Jun 2017

New cranberry derivative could help patients dependent on tube feeding

Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.

28 Jun 2017

Pharmaceutical giant Roche funds concept study aiming to find cure for Angelman syndrome

A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world’s largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.

28 Jun 2017

seca and B. Braun TravaCare optimize nutrition medicine follow-up care with validated BIA technology

seca, the world market leader in medical measuring systems and scales, and B. Braun TravaCare, experts for parenteral nutrition at home, optimize the quality of nutrition medicine follow-up care with the use of validated Bioelectrical Impedance Analysis technology from seca.

From seca 28 Jun 2017